References
- Haga SB, LaPointe NMA. The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J. 2013;13(6):481–483.
- U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling. Available at: fda.gov/drugs/sciencere-search/researchareas/pharmacogenetics/ucm083378.htm. Last accessed Aug. 1, 2016.
- Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89(3):464–467.
- Lee AM, Shi Q, Pavey E, et al. DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147). J Natl Cancer Inst. 2014;106(12):dju298.
- Deenen MJ, Meulendijks D, Cats A, et al. Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis. J Clin Oncol. 2016;34(3):227–234.
- Caudle KE, Thorn CF, Klein TE, et al. Clinical Pharmacogenetic Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013;94(6):640–645.
- Weitzel KW, Alexander M, Bernhardt BA, et al. The IGNITE network: A model for genomic medicine implementation and research. BMC Med Genomics. 2016;9(1):1.
- Crews KR, Cross SJ, McCormick JN, et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 68:143–50, 2011.
- Hicks JK, Crews KR, Hoffman JM, et al. A clinician driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharm Ther. 92(5):563–566, 2012.
- Bell GC, Crews KR, Wilkinson MR, et al. Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc. August 26, 2013.
- Mills R, Haga SB. Clinical delivery of pharmacogenetic testing services: A proposed partnership between genetic counselors and pharmacists. Pharmacogenomics. 2013;14(8):957–968.
- American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in clinical pharmacogenomics. Am J Health Syst Pharm. 2015;72:579–581.
- Relling MV, Gardner EE, Sandborn WJ, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther. 2011;89(3):387–391.
- Relling MV, Gardner EE, Sandborn WJ, et al. Clinical pharmacogenetics implementation consortium guidelines for Thiopurine methyltransferase genotype and Thiopurine dosing: 2013 update. Clin Pharmacol Ther. 2013;93(4):324–325.